Intro to Autophagy Daily Live 8/25/26

Key wellness + self-care / productivity strategies discussed

1) Track foundational blood-health markers (start with your CBC)

• Review red and white blood cell status because new red blood cells are produced in bone marrow from stem cells.
• Use CBC results to understand:
  • Anemia
  • Iron status (high vs. low)
  • Whether you absorb iron well

2) Avoid “default” iron supplementation—use it only when indicated

• If your iron is low or you don’t absorb iron, iron may be needed.
• If you bleed (e.g., menstruation), iron needs may differ.
• If you’re a man who doesn’t bleed and your iron/blood counts are normal:
  • Avoid extra iron
• If you’re a woman who doesn’t bleed and your hematocrit/hemoglobin are normal:
  • Avoid extra iron
• Rationale given: iron is tied to heme, which supports oxygen transport to mitochondria.

3) Focus on B12 + folate/methylation for healthy red blood cell formation

• If you’re making new red blood cells and B12/folate are insufficient, problems can occur early in red blood cell (RBC) development.
• Mechanistic emphasis:
  • Folate / synthetic folic acid supports methylation pathways.
  • B12 helps convert intermediates in the pathway that support normal cell/antioxidant function.

4) Prefer precision nutrition over guesswork (use gene-informed testing)

The speaker frames DNA testing as a “road map” to personalize nutrition/behavior based on methylation/detox and other pathways.

• DNA/methylation concepts explained as:
  • DNA must be methylated or acetylated in the right places to “unspool” for protein production.
• The methylation pathway is linked to:
  • folate/folic acid intake
  • ATP-dependent enzyme steps
  • conversion steps involving B12
  • downstream production of methionine → homocysteine → (cysteine) → glutathione
• Wellness takeaway: instead of relying on broad internet advice (e.g., “everyone needs glutathione”), check your gene results first.

5) Use the right supplementation only if your genes/labs indicate you need it

• Example given:
  • If glutathione-related steps are suboptimal on the test, they may recommend N-acetylcysteine (especially when “sick” is referenced).
• If your glutathione genes are already strong:
  • You may not need to “turn over that rock” or add more glutathione-focused supplements.

6) Support detoxification through pathway clarity, not one-size-fits-all stacks

• Glutathione is described as involved in eliminating:
  • heavy metals
  • pesticides
  • excess estrogen
  • other toxins / stressors
• Strategy: identify which detox steps are weak via testing, rather than blindly adding supplements.

7) Consider inflammation, vascular support, and clot-risk pathways

Testing categories referenced include:

• Inflammation markers (including inflammatory cytokines)
• Omega-3 processing
• Nitric oxide production (capillary/blood vessel dilation)
• Histamine-related pathways (HMNT mentioned)
• Atherosclerosis / blood clot risk factors, including:
  • Factor V and clot risk
  • risk amplification discussed with estrogen
• Angiotensin system factor mentioned (angiotensin/renin-angiotensin system factor 10 referenced)
• Hormone metabolism and thyroid genes are also noted as relevant to clot and health risk.

8) Autophagy and mitochondrial quality control are linked to gene checks (DNA-informed)

• “Autophagy genes” are described as related to cellular recycling.
• The speaker also discusses mitochondrial gene-related areas (noting regulatory constraints such as the FDA removing certain genes from their panel).

9) Match fasting/ketosis to adequate nutrition—avoid under-eating nutrients

Key caution: under-eating or excessive fasting/being “skinny fat” (or missing foods) can lead to insufficient building blocks:

• iron
• folate
• B12

The speaker argues that long fasting without adequate nutrition makes proper methylation/acetylation “retagging” difficult.

If your goal is recycling/rebuilding cells, you still need nutrients to support the process.

10) Use testing to decide what to ask your doctor

• The DNA panel is presented as:
  • mapping likely pathway bottlenecks
  • guiding what to discuss with a clinician
  • helping interpret whether symptoms might connect to methylation/detox/inflammation/hormone/vascular pathways

---

Presenters / sources mentioned

• Gel (speaker; referenced multiple times as “Gel will post this” and “I will see you tomorrow”)
• Harvard (mentioned via “Khill Stories at Harvard” and a supervised fasting example)
• FDA (mentioned regarding removal of certain mitochondrial-related genes from the panel)
• Customs/Tariffs (mentioned as a reason for test availability limits outside the U.S.)

(No other specific medical authors or named research papers were cited in the subtitles.)